Compositions and methods for diagnosing and treating degenerative mitral valve disease in a canine

Abstract

Methods and compositions diagnose and treat degenerative mitral valve disease in a canine. A method of diagnosing early stage degenerative mitral valve disease in a canine can include measuring a normalized relative abundance of a biomarker selected from the group consisting of Erysipelatoclostridium, Ruminococcaceae UCG014, Butyricicoccus, Faecalibacterium, and combinations thereof; and determining that the canine has early stage degenerative mitral valve disease if the Erysipelatoclostridium is from 0 to 0.5 normalized relative abundance, the Ruminococcaceae UCG014 is from 0 to 0.1 normalized relative abundance, the Butyricicoccus is from 0 to 0.1 normalized relative abundance, or the Faecalibacterium is from 0 to 0.1 normalized relative abundance.

Dependencies are inferred from the claim text.